SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-118499
Filing Date
2023-04-26
Accepted
2023-04-26 16:05:58
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A d770901ddefa14a.htm DEFA14A 26455
2 GRAPHIC g770901sp5a.jpg GRAPHIC 3678
3 GRAPHIC g770901sp5b.jpg GRAPHIC 1303
4 GRAPHIC g770901sp5c.jpg GRAPHIC 1285
5 GRAPHIC g770901sp5d.jpg GRAPHIC 890
6 GRAPHIC g770901sp5e.jpg GRAPHIC 929
7 GRAPHIC g770901sp5f.jpg GRAPHIC 1212
  Complete submission text file 0001193125-23-118499.txt   41158
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36014 | Film No.: 23849711
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences